Skip to content

Frontlight ResearchEarly access

Trial site

St. Louis Heart & Vascular, PC

St Louis, Missouri 63136, United StatesNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Heart failure

Closed trials

Completed
A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection Fraction
NCT06195930· Phase 2· Bayer· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

St. Louis Heart & Vascular, PC: trial site – Frontlight Research